[Results of the treatment of myelodysplastic syndrome (MDS)obtained by the Polish Paediatric Leukaemia /Lymphoma Study Group].

Autor: Chybicka A; Klinika Hematologii i Chorób Rozrostowych Dzieci, 50-345 Wroclaw, ul. Bujwida 44, Poland., Wójcik D, Pietras W, Bogusławska-Jaworska J, Kolecki P, Balcerska A, Balwierz W, Bubała H, Eliasinska A, Kowalczyk J, Jackowska T, Klus K, Krenke K, Kurylak A, Malinowska I, Matysiak M, Stefańska K, Stefaniak MJ, Rokicka-Milewska R, Wiśniewska-Slusarz H, Sońta-Jakimczyk D, Wysocki M
Jazyk: polština
Zdroj: Medycyna wieku rozwojowego [Med Wieku Rozwoj] 2000; Vol. 4 (1 Suppl 2), pp. 85-90.
Abstrakt: Sixty children with MDS treated in six centres of the Polish Paediatric Leukaemia/Lymphoma Study Group in the period 1975-1999 were included in the study. In 20 children RAEB-T, in 13 RA, in 21 RAEB and in 6 CMML were diagnosed. Our own and literature data showed that BMT is the best therapy for children with MDS. We need a new comprehensive protocol for the diagnosis and treatment of children with MDS in Poland.
Databáze: MEDLINE